Impact of hepatitis B core antibody (anti HBc) seropositivity on interferon/iribavirin treatment response in patients with chronic hepatitis C

Biyikoglu I., Filik L., Oguz D., Cicek B., Yilmaz B., Altiparmak E.

BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, cilt.108, sa.2, ss.65-69, 2007 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 108 Sayı: 2
  • Basım Tarihi: 2007
  • Dergi Adı: BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.65-69
  • Anahtar Kelimeler: hepatitis B, antibody, antiHBc-seropositivity, interferon, ribavirin, chronic hepatitis C
  • Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

AntiHBc seropositivity among patients with chronic HCV infection is not a rare entity (57.14 %). We observed that antiHBc antibody seropositivity does not have a significant impact on treatment responses to interferon/ribavirin therapy in patients for chronic HCV infection in contrast to some reports in the literature.